# External Versus Powered Endoscopic Dacryocystorhinostomy With Mitomycin C for Primary Acquired Nasolacrimal Duct Obstruction

> **NCT07754058** · NA · COMPLETED · sponsor: **Military Institute od Medicine National Research Institute** · enrollment: 60 (actual)

## Conditions studied

- Primary Acquired Nasolacrimal Duct Obstruction

## Interventions

- **PROCEDURE:** External Dacryocystorhinostomy
- **PROCEDURE:** Powered Endoscopic Dacryocystorhinostomy
- **DRUG:** Mitomycin C 0.02%

## Key facts

- **NCT ID:** NCT07754058
- **Lead sponsor:** Military Institute od Medicine National Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-18
- **Primary completion:** 2026-03-12
- **Final completion:** 2026-03-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07754058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07754058, "External Versus Powered Endoscopic Dacryocystorhinostomy With Mitomycin C for Primary Acquired Nasolacrimal Duct Obstruction". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07754058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*